Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-24-019043

President & CEO sold 20,033 shares at $0.68 ($13,622)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2024-02-20 Sale −20,033 $0.68 $13,622 879,889 D: show line 1 in the form
Open-market sales · 20,033 sh · avg $0.68 · $13,622
Loading xslF345X05/ownership.xml…